pennews
www.pennews.net
Dr Reddy’s stops transaction with Upsher-Smith Lab
Business

Dr Reddy’s stops transaction with Upsher-Smith Lab

Agency News

Hyderabad, Jul 20 : Dr Reddy’s Laboratories on Saturday announced the closure of the transaction with Upsher-Smith Laboratories, LLC (Upsher-Smith), pursuant to the satisfactory completion of all customary closing conditions including the applicable waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (HSR Act), as amended.

Under the agreement Dr Reddy’s sold its US and select territory rights for Zembrace Symtoch (sumatriptan injection) 3 mg and Tosymratm (sumatriptan nasal spray) 10 mg, which were commercialized through its wholly owned subsidiary, Promius Pharma, LLC, a company statement here said. (UNI)